S126: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL

Bibliographic Details
Main Authors:	N. Russell, C. Wilhelm-Benartzi, J. Othman, R. Dillon, N. Potter, J. Jovanovic, A. Gilkes, L. M. Batten, J. Canham, E. L. Hinson, P. Kottaridis, J. Cavenagh, C. Arnold, M. Dennis, S. Knapper
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843396.14484.b9

Internet